Patient Safety & Systems-Based Practice
Telemedicine: appropriate use and limitations
— Expands access (rural, mobility-limited, behavioral health, transplant follow-up)
— Reduces no-show rates, travel burden, infectious exposure
— Supports longitudinal chronic disease management (HTN, DM, HF, COPD, mental health)
— Enables specialty reach (tele-stroke, tele-ICU, tele-psych, tele-derm)
— Stable chronic disease follow-up with home data (BP cuff, glucometer, weight, SpO₂)
— Medication titration/refills, lab review, results communication
— Behavioral health visits (depression, anxiety, MAT for OUD with appropriate registration)
— Triage of low-acuity acute complaints (UTI symptoms, conjunctivitis, URI, rashes with good camera)
— Post-op wound checks, post-discharge transition visits within 7–14 days
— Counseling: contraception, smoking cessation, lifestyle, pre-test/genetic
— Any unstable vitals or red-flag symptoms (chest pain with features, dyspnea at rest, focal neuro deficit outside a tele-stroke protocol, suicidal intent requiring safety placement)
— Required pelvic, rectal, breast, or detailed musculoskeletal/neuro exam
— Procedures, injections, joint aspiration, biopsy
— New controlled substance prescribing where state/DEA in-person rules apply
— Severe sensory/cognitive impairment without caregiver support
Board pearl: On Step 3, the correct answer is rarely "do everything by telehealth" or "never use telehealth"—it is matching modality to acuity and exam requirements, with a clear pathway to escalate to in-person or ED when red flags emerge.

— Confirm patient identity (full name, DOB, photo ID if new), current physical location (state + address), and a callback number in case of disconnection
— Verify the clinician is licensed in the state where the patient is physically located at the time of the visit
— Obtain and document verbal informed consent for telehealth, including limitations and privacy risks
— Ensure HIPAA-compliant platform (post–public health emergency, consumer apps like FaceTime/Zoom personal are no longer broadly permitted)
— Open-ended onset/quality/timing remains identical to in-person
— Explicitly ask about red-flag symptoms because you cannot "lay hands"—chest pain, dyspnea, syncope, focal weakness, vision loss, severe abdominal pain, suicidal/homicidal ideation, abuse
— Ask about home devices: BP cuff brand and cuff size, glucometer, scale, pulse oximeter, peak flow, CGM data
— Medication reconciliation with "brown bag" on camera—have patient hold up bottles
— Confirm pharmacy of choice and insurance/coverage for any e-prescription
— Is the patient alone? Privacy is essential for IPV screening, mental health, sexual health
— Lighting, camera angle, ambient noise (impacts exam quality)
— Caregiver present? Document role and patient consent for them to remain
— Children, firearms, fall hazards visible (opportunity for anticipatory guidance)
Step 3 management: If during a telehealth visit the patient discloses active suicidal ideation with plan, the correct next step is do not end the call—keep the patient on the line, confirm location, involve a co-located adult or activate 988/EMS to the verified address, and arrange ED evaluation. Document location verification at the start of every encounter for this reason.

— Heart rate from home BP cuff or palpated radial pulse with you counting
— BP from validated upper-arm oscillometric cuff, correct cuff size, seated 5 min, feet flat, arm at heart level—wrist/finger cuffs unreliable
— SpO₂ from fingertip oximeter (warn about nail polish, cold fingers, poor perfusion)
— Temperature, weight, respiratory rate by direct observation
— Orthostatics: have patient lie, then stand, recheck BP/HR at 1 and 3 minutes
— HEENT/skin: good lighting, ruler or coin for scale, multiple angles, dermoscopy attachments where available
— Pulmonary: count RR over 30 s on camera, observe accessory muscle use, ask patient to speak in full sentences, "walk test" with pulse ox if dyspnea workup
— Cardiac: JVP estimation difficult; assess for peripheral edema by pressing shin on camera; digital stethoscopes exist but rarely required
— Abdominal: observe patient palpate own abdomen, watch for guarding/grimace; rebound and rigidity cannot be assessed → in-person if suspected
— Neuro: cranial nerves (smile, EOM, tongue), pronator drift, finger-to-nose, gait across the room, NIH Stroke Scale modified for telehealth in tele-stroke protocols
— MSK: active ROM, point tenderness self-palpation, special tests with caregiver assistance
— Psych: mental status, affect, thought process, suicide risk assessment are well-suited to video
— SBP <90 or >180 with symptoms, HR <40 or >130, SpO₂ <92% on room air new, RR >24, altered mental status
Key distinction: Telehealth can reliably assess observation-based findings (rash, gait, affect, work of breathing) but cannot replace auscultation, palpation for masses, pelvic/rectal exam, or detailed neuro testing—if these are diagnostically pivotal, convert to in-person.

— Labs and imaging can be ordered to a facility near the patient; verify the patient can physically and financially access it
— Use remote patient monitoring (RPM) data: home BP logs (≥12–14 readings over 7 days for HTN dx per AHA/ACC), CGM time-in-range, daily weights for HF, peak flows for asthma, PHQ-9/GAD-7 via portal
— Validated home BP devices: prefer those on the US Blood Pressure Validated Device Listing
— Patient-submitted photos for dermatology, wound care, ophthalmology (red eye), pediatric rashes
— Require: ≥2 images, ruler for scale, multiple angles, good lighting, time-stamped
— Tele-radiology and tele-pathology underlie many specialty consults
— HTN: Office BP elevated → confirm with home BP monitoring or ABPM before labeling HTN (avoid white-coat misclassification)
— Diabetes: Use CGM ambulatory glucose profile (AGP) to guide titration; HbA1c every 3–6 months via local draw
— HF: Daily weight + symptom log; ≥2 lb/day or 5 lb/week gain → diuretic adjustment via telehealth call
— Depression/anxiety: PHQ-9, GAD-7 at every visit; measurement-based care is the standard
— Anticoagulation: Home INR monitoring for warfarin; DOACs preferred to minimize monitoring
— Cannot do point-of-care urinalysis, strep swab, EKG, spirometry, or imaging in real time
— Home pulse ox can be inaccurate in dark skin tones at low saturations—do not rely on isolated readings to rule out hypoxemia
Board pearl: When a vignette gives office BP 150/95 once, do NOT start a drug—correct answer is confirm with home BP monitoring or ABPM (USPSTF/ACC/AHA), a perfect telehealth-integrated workflow.

— Primary care submits clinical question + data → specialist reviews chart and replies, often within 1–3 business days
— Appropriate for: stable thyroid nodule with benign features, mild proteinuria, isolated LFT abnormality, dermatology lesion triage, ECG interpretation, hepatitis B serology interpretation
— Reduces unnecessary in-person specialty visits, shortens wait times, and is reimbursable under CPT 99446–99452
— Tele-stroke: Video NIHSS by vascular neurologist + local non-contrast CT/CTA → tPA/TNK decision; door-to-needle metrics equivalent to in-person stroke centers
— Tele-psychiatry: Structured diagnostic interviews (MINI, SCID-lite) are validated by video
— Tele-dermatology: Sensitivity/specificity for melanoma triage approaches in-person when image quality is adequate; suspicious lesions still require in-person biopsy
— Tele-ophthalmology: Diabetic retinopathy screening with retinal cameras at PCP offices, read remotely—endorsed by ADA for annual screening
— Tele-cardiology: Remote interrogation of pacemakers/ICDs (HRS recommends every 3–12 months); event monitors and patch ECGs transmitted to reading center
— Appropriate for high pre-test probability OSA in otherwise uncomplicated adults
— Not appropriate for significant cardiopulmonary disease, suspected central apnea, or pediatrics → in-lab PSG
Step 3 management: For a stable PCP question like "isolated TSH 6.5 with normal free T4 in a 55-year-old", an endocrinology e-consult is often a more efficient correct answer than a referral visit—test recognizes that e-consults are a legitimate, billable level of care.

— In-person required: unstable vitals, acute abdomen, new focal neuro deficit, severe pain, procedure needed, mandatory exam, new controlled substance per regulations, complex pediatric exam, prenatal physical milestones
— Synchronous video preferred: new patient evaluations, mental status assessment, dermatologic complaints, gait/neuro screen, family meetings, high-stakes communication (goals of care, breaking bad news—better than phone)
— Audio-only acceptable: established patient, simple follow-up, technology/access barrier, results review without visual component; many payers reimburse audio-only with appropriate modifier
— Asynchronous (portal/e-visit): medication refills, simple symptom triage, form completion, lab result questions
— RPM: chronic disease with actionable home data (HTN, DM, HF, COPD, post-op recovery)
— Limited digital literacy, vision/hearing impairment without accommodations, primary language differences requiring interpreter (use a certified video medical interpreter—never family for sensitive content), unstable housing, lack of private space, suspected abuse
— Broadband access, device ownership, and digital literacy correlate with income, age, race, and rurality
— Audio-only options, language-concordant care, and asynchronous workflows mitigate disparities
— Quality programs should measure telehealth use stratified by demographics to detect inequity
Key distinction: Step 3 distinguishes "can be done by telehealth" (technically feasible) from "should be done by telehealth" (clinically and ethically appropriate for this patient). When the vignette stresses access barriers, language, or disability, the right answer often includes a specific accommodation (interpreter, captioning, caregiver, in-person option offered).

— Non-controlled medications: routinely prescribed during telehealth nationwide; verify pharmacy, allergies, interactions, and adherence
— Always perform medication reconciliation on camera, including OTC, supplements, and recent antibiotics/steroids
— Send prescriptions electronically (EPCS for controls) to a single designated pharmacy
— Under the Ryan Haight Act, an in-person evaluation is generally required before a practitioner may prescribe a controlled substance via telemedicine, unless a regulatory exception applies
— Pandemic-era flexibilities (no prior in-person visit needed) have been extended by DEA through specific end dates and are subject to change—know the principle, not the date
— Buprenorphine for OUD: May currently be initiated via audio-video (and audio-only under extended flexibilities) telemedicine; X-waiver requirement was eliminated by the MAT Act—any DEA-registered prescriber can prescribe within their scope
— Schedule II stimulants for ADHD: most scrutinized; check state PDMP every prescription regardless of modality
— Query state Prescription Drug Monitoring Program (PDMP) before prescribing
— Use treatment agreement, urine drug screening as appropriate
— Avoid concurrent benzodiazepine + opioid prescribing
— Document medical necessity, prior treatments tried, and ongoing monitoring plan
— Telehealth visits carry a documented risk of antibiotic overprescribing for viral URIs—delay prescriptions, watchful waiting, and clear return precautions are tested correct answers
Board pearl: For a patient with uncomplicated OUD seen by video, starting sublingual buprenorphine via telehealth with a same-week follow-up is currently appropriate and improves retention—do not delay treatment waiting for an in-person visit.

— CPT 99453 (setup), 99454 (device supply, ≥16 days of data in 30 days), 99457/99458 (clinician time, ≥20 min/month)
— Requires ≥16 days of physiologic data each 30-day period to bill device codes
— Best evidence: HTN control, glycemic control, HF readmission reduction
— Non–face-to-face care coordination for patients with chronic conditions; 20+ minutes/month, written patient consent, comprehensive care plan
— Particularly suited to telehealth-integrated practices
— Continuous remote intensivist + critical care RN coverage of ICU beds; associated with reduced mortality and LOS in some studies, particularly in low-volume or rural ICUs
— Eligible diagnoses (cellulitis, pneumonia, HF exacerbation, COPD exacerbation, UTI) managed at home with daily MD visit (in-person or video), twice-daily RN, IV therapy, RPM
— Requires patient hemodynamic stability, suitable home environment, caregiver support
— Hub-and-spoke models bring expertise to rural EDs and primary care, expanding access to thrombolysis and psychiatric care
— Use place-of-service code 02 (telehealth not in patient home) or 10 (telehealth in patient home); modifier 95 for synchronous audio-video, 93 for audio-only
— Document modality, patient location, clinician location, time, and consent
CCS pearl: On a CCS-style case, after stabilizing a patient with HFrEF exacerbation, "enroll in RPM with daily weights and BP" + "schedule 7-day post-discharge tele-visit" is a high-value transition order that targets the 30-day readmission penalty.

— Reduces transportation burden, fall risk, caregiver time off work
— Enables in-home cognitive and functional assessment (observe home environment, fall hazards, medication storage)
— Validated tools: Mini-Cog, MoCA-blind/audio version, geriatric depression scale by video
— Sensory impairment: hearing loss (use captioning, amplified phone), low vision (large fonts, audio-only fallback)
— Cognitive impairment: include caregiver with patient consent; verify decisional capacity for treatment decisions
— Lower rates of broadband and device ownership; offer audio-only and provide tech support
— Polypharmacy review is especially high-yield by telehealth ("brown bag" review)
— Frailty, orthostatics, gait/balance (Timed Up and Go can be done by video with caregiver), skin breakdown over sacrum/heels often require in-person
— Telehealth well-suited for nephrology follow-up, BP titration, dietary counseling, transplant pre/post evaluation
— Home hemodialysis and peritoneal dialysis patients particularly benefit from RPM (BP, weight, exit-site photos)
— Adjust renally cleared medications when e-prescribing; verify recent eGFR before nephrotoxic prescriptions
— HCV treatment, MASLD counseling, and HCC surveillance scheduling (US q6 months) all telehealth-friendly
— Avoid telehealth-only management of decompensated cirrhosis with new ascites or encephalopathy—needs in-person exam and often labs same-day
Step 3 management: For a frail 82-year-old with multiple chronic conditions, a hybrid model—quarterly in-person + interval video check-ins + RPM for BP/weight + caregiver involvement—is the highest-yield correct answer, not "all telehealth" or "all in-person."

— ACOG endorses hybrid prenatal care: combination of in-person visits (for fundal height, fetal heart tones, GBS, anatomy scan) with telehealth visits for counseling, mental health screening, BP review
— Home BP monitoring central to outpatient management of gestational hypertension and chronic HTN in pregnancy; daily BP + symptom log
— Postpartum visits: the comprehensive postpartum visit by 12 weeks can include telehealth components, especially for PPD screening (EPDS), contraception counseling, lactation support
— Limitations: cannot perform speculum exam, fundal height after 24 weeks, fetal heart auscultation reliably at home
— Well-child visits requiring immunizations, growth measurements, and full exam = in-person
— Telehealth roles: ADHD follow-up and titration, asthma action plan review, mental/behavioral health, lactation, mild URI/dermatology triage, post-op checks
— Mandatory reporter status applies in telehealth—if concern for child abuse arises (suspicious injury seen on camera, disclosure), file a report; the modality does not change the duty
— Verify caregiver identity and legal guardianship; consent rules for adolescent confidential services (contraception, STI, mental health, substance use) vary by state and apply to telehealth
— Strong evidence: CBT, IPT, medication management for depression/anxiety, ADHD follow-up, MAT for OUD
— Less ideal: active suicidality requiring ED evaluation, severe eating disorders requiring weight checks, first-episode psychosis assessment
— Confirm a safe, private space—if not, reschedule or convert modality
— Telehealth can be a barrier (abuser nearby) or facilitator (visit while abuser away); use yes/no scripted questions and a code word/safety plan
Board pearl: If a pregnant patient with gestational HTN has home BP ≥160/110 confirmed on repeat or any severe-range symptom (headache, RUQ pain, visual changes), the answer is immediate in-person/L&D evaluation, never "continue home monitoring."

— Missed physical exam findings (murmur, mass, peritoneal signs, subtle neuro deficit)
— Over-reliance on patient-reported data; confirmation bias when working from a chief complaint without exam
— Image quality issues in tele-dermatology leading to missed melanoma
— Mitigation: low threshold to convert to in-person, structured "return precautions," safety-netting language documented
— Direct-to-consumer telehealth platforms show higher antibiotic rates for URI; ADHD stimulant prescribing scrutiny
— Non–HIPAA-compliant platforms, public Wi-Fi, screenshots, family members overhearing
— Recording without explicit consent violates wiretap laws in many states
— Dropped calls, audio-only fallback, EMR downtime—must have a documented backup plan (callback number, reschedule pathway)
— Patients without broadband or devices may receive lower-quality audio-only care or no care—worsens disparities if not actively mitigated
— Practicing across state lines without proper licensure exposes clinician to disciplinary action and malpractice coverage gaps
— Standard of care = same as in-person; "I couldn't examine them" is not a defense if the appropriate action was to convert to in-person
— Document modality, consent, limitations acknowledged, and rationale for telehealth being appropriate
— Missed ectopic in patient with "spotting" managed by video
— Missed appendicitis in patient with "GI bug" by phone
— Missed sepsis in elderly with vague malaise
Key distinction: Telehealth does not lower the standard of care—if a complete exam is required to meet that standard, the clinician must arrange in-person evaluation or refer to ED. Convenience never overrides clinical necessity.

— Chest pain with ACS features, severe dyspnea, anaphylaxis signs, stroke symptoms within window, syncope with abnormal vitals, severe abdominal pain with peritoneal signs reported, altered mental status, active suicidal plan with means, overdose, obstetric emergency
— Stay on the line, confirm address, dispatch EMS, and notify receiving ED
— New focal neuro deficit outside thrombolytic window, severe pain requiring parenteral analgesia, suspected DVT/PE with hemodynamic stability, severe hyperglycemia with ketosis, BP severe range with end-organ symptoms
— Need for pelvic, rectal, joint exam, ENT exam, fundoscopy
— Need for in-office testing: strep, UA, urine pregnancy, EKG, spirometry, point-of-care US
— Procedural needs: I&D, joint injection, IUD, suture removal complications
— Tele-stroke → stroke center transfer
— Tele-psychiatry → mobile crisis or inpatient psych
— Hospital-at-home → escalate to hospital if deterioration
— Suspected sepsis, suspected MI, suspected stroke, suspected ectopic, suspected testicular torsion, severe pediatric dehydration, suspected child or elder abuse requiring immediate safety intervention
CCS pearl: On a CCS case that opens with a telehealth visit and any unstable vital sign (SBP <90, HR >130, SpO₂ <90%, GCS drop), the immediate orders are "end telehealth visit, activate EMS to verified patient address, transfer to ED"—delay in escalation is the most penalized error pattern.

— Gold standard for full exam, procedures, vaccines, in-office labs
— Required for new controlled substances (with current exceptions), high-acuity complaints, and many procedures
— Subset of telehealth; appropriate when video unavailable, patient lacks device, or visual exam not needed
— Reimbursed under audio-only telehealth codes with modifier 93; some payers limit to established patients
— Patient-initiated written exchange addressing a clinical issue, ≥5 minutes cumulative provider time over 7 days
— CPT 99421–99423; appropriate for low-complexity issues
— 5–10 minute communication to determine whether an office visit is needed (HCPCS G2012); not a substitute for a full visit
— RPM: physiologic data (BP, glucose, weight, SpO₂)
— RTM: non-physiologic therapeutic data (musculoskeletal, respiratory adherence, CBT homework)
— In-person home services for wound care, IV therapy, PT/OT; can be combined with physician telehealth oversight
— Same-day acute low-acuity in-person care; often the right "convert to in-person" destination from telehealth triage
— High-acuity destination; tele-triage can direct patients here efficiently
Step 3 management: When the vignette emphasizes "5-minute question about a recent lab", the most efficient correct answer may be a virtual check-in or e-visit rather than scheduling a full video visit—right-sizing the modality is itself a tested competency.

— Risks: fragmentation, no PCP follow-up, antibiotic/controlled overprescribing, missed serious diagnoses, prescribing without adequate workup
— Quality marker: ability to communicate back to the patient's PCP and EHR
— Each state's medical board generally requires licensure where the patient is located at the time of the visit
— Interstate Medical Licensure Compact (IMLC) expedites multi-state licensure for eligible MDs/DOs; PSYPACT for psychologists; NLC for nurses
— Some states have limited telehealth registrations or exceptions for follow-up of established patients
— Weight-loss/GLP-1 mills without comorbidity assessment
— Testosterone, hormonal therapy, ED medications prescribed without exam or labs
— Stimulant prescribing without diagnostic interview or comorbidity assessment
— Pap smears, mammograms, colonoscopy, immunizations—telehealth can order/counsel but cannot perform
— Genital/rectal complaints, suspected abuse, complex pain syndromes—the temptation to "handle by video" must be resisted when exam is pivotal
— Mental status, dermatologic complaints, neuro complaints generally need video if technically feasible
Key distinction: A high-quality telehealth program is integrated with in-person care, EHR, labs, and pharmacy—DTC fragmented platforms are the boards' archetype of misuse. Look for vignette cues like "no PCP," "ordered antibiotics online," or "got testosterone from a website."

— Schedule within 7–14 days of hospital discharge; CMS Transitional Care Management (CPT 99495/99496) requires interactive contact within 2 business days and face-to-face (in-person or telehealth) within 7 or 14 days
— Components: medication reconciliation, review of discharge summary, pending labs/follow-up appointments, red-flag teaching, durable medical equipment confirmation
— HTN: home BP twice daily for 1 week each month, target <130/80, monthly telehealth titration until controlled, then quarterly
— DM: CGM review every 2–4 weeks during titration, A1c q3 months, annual retina (tele-ophth), foot exam in person annually, nephropathy screen
— HFrEF: GDMT titration every 1–2 weeks via video until target doses, daily weights, RPM for diuretic adjustment
— COPD: action plan review, inhaler technique on camera, smoking cessation
— Depression/anxiety: PHQ-9/GAD-7 every visit, measurement-based titration
— Order screening (mammogram, colon CA—stool-based options enable home-based screening; FIT or Cologuard kit mailed), vaccines (schedule at pharmacy or office)
— Counseling: smoking cessation, alcohol use reduction (SBIRT), nutrition, exercise, contraception
— Written/portal-delivered after-visit summary in plain language with return precautions and explicit "call 911 if..." criteria
Board pearl: A 7-day post-discharge telehealth visit after a CHF admission counts for CMS transitional care management and is associated with lower 30-day readmissions—appropriate answer when the vignette emphasizes access barriers or transportation.

— Stable HTN: every 3–6 months once at goal; monthly during titration
— Stable T2DM: every 3 months until at goal; every 6 months once stable
— Stable HFrEF on GDMT at target: every 3 months
— Stable depression on therapy: every 2–4 weeks initially, then every 1–3 months
— Anticoagulation (DOAC): every 6–12 months with annual labs (CBC, CMP)
— OUD on buprenorphine: weekly to monthly initially, then monthly to quarterly
— Vital sign trends from RPM (alert thresholds set by clinician)
— Symptom diaries (HF, asthma, migraine, mood)
— Adherence (pharmacy refill data, MEMS caps, patient self-report)
— Side effect surveillance via standardized questionnaires
— How to take and log home BP/glucose/weight
— When to call vs. message vs. go to ED
— Medication adherence and side-effect reporting
— Lifestyle: DASH/Mediterranean diet, 150 min/week moderate activity, alcohol limits, tobacco cessation
— Vaccination schedule appropriate to age and comorbidity
— Cardiac rehab (home-based), pulmonary rehab, PT/OT (RTM), cognitive rehab—growing evidence supports outcomes comparable to facility-based for selected patients
— Family meetings by video improve attendance and inclusion of distant relatives; useful for goals-of-care discussions, palliative care, advance care planning
Step 3 management: When a patient with newly diagnosed HTN starts amlodipine, the highest-yield follow-up is a 2- to 4-week telehealth visit with home BP log review—not "return to clinic in 3 months," which delays titration.

— Must include nature of telehealth, alternative of in-person care, limitations of remote exam, privacy/security risks, and right to discontinue
— Document verbal or written consent at the first telehealth visit and annually; many states require state-specific language
— Clinician must be licensed in the state where the patient is physically located at the time of the visit
— Verify patient location at the start of every encounter—patients travel, and a visit started in a non-licensed state is unauthorized practice
— Use HIPAA-compliant platforms with Business Associate Agreements
— Confirm patient is in a private space; if not, offer to reschedule or limit content
— Document who else is present and patient consent for their presence
— Suspected child abuse, elder abuse, IPV (in mandated states), certain communicable diseases, gunshot wounds, impaired drivers (state-specific)—report from telehealth as from in-person
— Comply with Ryan Haight Act and current DEA telemedicine rules; document medical necessity; use PDMP
— Generally feasible; document understanding, appreciation, reasoning, and ability to express a choice
— Provide interpreters (certified medical interpreter, never family/minor children for clinical content), accommodations for hearing/vision impairment, audio-only fallback, and avoidance of digital-divide harms
— Telehealth between settings (hospital→home, ED→PCP) is a known high-risk handoff; structured medication reconciliation and explicit follow-up plan are critical
— Modality, consent, patient and clinician location, anyone else present, technology issues, limitations of exam, rationale for telehealth, and follow-up plan
Board pearl: A scenario where a patient calls from another state on vacation requesting a refill of a controlled substance is the classic wrong-answer trap—correct response is to defer refill, direct to local urgent care/ED if needed, and arrange follow-up upon return, not to prescribe across state lines outside licensure.

Key distinction: Telehealth is a modality, not a specialty—competency requires matching the modality to the clinical task, with the same diagnostic and ethical rigor as in-person care.

Board pearl: When a stem describes any red-flag symptom + a telehealth setting, the answer is virtually always escalate to in-person/ED, not "manage by video."

Telemedicine is a delivery modality that, when matched to clinical acuity, exam requirements, regulatory rules, and patient context, expands access and improves longitudinal care—but never lowers the standard of care or replaces an in-person evaluation when one is required.
Key distinction: The Step 3 examiner rewards judgment about when to use telehealth, not enthusiasm for the technology itself—the best clinician integrates modalities into a coherent, longitudinal, safe, and equitable plan of care.

